Frost & Sullivan Commends Nutraceutix's Superlative Commercial Performance in the North American Probiotics Market

With a dedication to credible research and product quality, Nutraceutix adds value industry-wide

Oct 01, 2015, 09:00 ET from Frost & Sullivan

MOUNTAIN VIEW, Calif., Oct. 1, 2015 /PRNewswire/ -- Based on its recent analysis of the probiotics market, Frost & Sullivan recognizes Nutraceutix with the 2015 North American Frost & Sullivan Company of the Year Award.  Nutraceutix is uniquely positioned as a visionary company in the maturing probiotic marketplace for delivering outstanding products. It has made the most of patented processes and technologies to help brands formulate and deliver the industry's finest premium probiotics in a variety of formulae and dietary supplement formats.

"Nutraceutix has 30 years of experience in the probiotics market and specializes in producing high viability probiotics in bulk powder, advanced capsules and tablet forms," said Frost & Sullivan Global Program Manager, Visionary Science, Christopher Shanahan. "With more than three dozen strains in its probiotic library and a dozen strains in production at any given time, Nutraceutix allows companies to create the right products and delivery methods to reach their target consumer base."

Nutraceutix stands out in the market for applying unique expertise, processes and technologies to enhance finished product shelf life and performance. If a customer is looking to brand and sell a particular strain and potency of probiotic for a specific condition, Nutraceutix will develop and optimize a custom solution, even if it means sourcing and incorporating ingredients and probiotic organisms from third parties. This approach enables Nutraceutix to thrive as a behind-the-scenes, supportive partner to quality conscious brands. It also sells its strains to other manufacturers and routinely cooperates with other players to address customer needs.

Furthermore, Nutraceutix partners with leading commercial and academic research institutions in probiotic research. For instance, it has worked on various occasions with researchers including those from Bastyr University and the German Diabetes Center to produce probiotic supplements in the BIO-tract® caplet format for research that demonstrated that these products, respectively, enhance immune function and modulate gut insulin metabolism in adults.

An early key participant and current member of the International Probiotics Association (IPA), Nutraceutix continues to promote credible R&D. It is aware of the regulatory frameworks in and outside of North America and complies with all relevant regulations and standards. Moreover, it operates exclusively in NSF International registered good manufacturing practices (cGMP)-compliant manufacturing facilities. This investment in quality and a continued quality improvement emphasis sets the tone for its customer relationships and sets it apart in the market.

As a result of its intense R&D efforts to develop the globally recognized, multi-patented LiveBac® processes and BIO-tract delivery systems, Nutraceutix has helped overcome key challenges in strain-independent probiotic delivery. LiveBac® processes ensure extended shelf life for probiotics, even at room temperature, and BIO-tract delivery technologies safeguard probiotic organisms from damage by stomach acid to help them reach optimal locations in the intestinal tract. The novel patented BIO-tract delivery technologies for tablets and capsules also enable desirable extended-release profiles customizable by formulation.

"Each of Nutraceutix's product enhancements are optimized to work with probiotics and resolve the issues inherent in shelf life stability and optimal delivery to the consumer. These same delivery technologies can also be put to use for novel controlled delivery nutraceuticals that may not include probiotics at all," noted Shanahan. "Overall, Nutraceutix's level of innovation and expertise has prompted customers to seek it out when formulating and developing multiple products within their brands."

Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in terms of growth strategy and implementation. The award recognizes a high degree of innovation with products and technologies, and the resulting leadership in terms of customer value and market penetration.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

About Nutraceutix

Headquartered in Redmond, Washington, Nutraceutix is an NSF Registered cGMP contract manufacturer and private labeler of probiotics and other premium nutritional supplements. The company specializes in producing high quality probiotics in bulk powder, capsules and tablets from its broad, factory direct offering of natural probiotic organisms.

Developed over 30 years, Nutraceutix has researched and patented unique processes and technologies that are used to formulate and produce superior probiotic dietary supplements.  Nutraceutix patents are recognized in over 30 countries around the world. Hallmarks of Nutraceutix-manufactured probiotic products, including LiveBac®, BIO-tract® and Viablend®, can be found on labels of dietary supplements distributed by many of the world's finest brands today. 

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:   Start the discussion
Join Us:      Join our community
Subscribe:    Newsletter on "the next big thing"
Register:     Gain access to visionary innovation

Contact:

Mireya Espinoza
P: 210. 247.3870
F: 210.348.1003
E: mireya.espinoza@frost.com

Nutraceutix
P: 425-883-9518
E: info@nutraceutix.com
W: www.nutraceutix.com

Photo - http://photos.prnewswire.com/prnh/20150930/272575

 

SOURCE Frost & Sullivan



RELATED LINKS

http://www.frost.com